Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders.
about
Mechanism of hypoxia-inducible factor 1 alpha-mediated Mcl1 regulation in Helicobacter pylori-infected human gastric epithelium.Small molecule activation of adaptive gene expression: tilorone or its analogs are novel potent activators of hypoxia inducible factor-1 that provide prophylaxis against stroke and spinal cord injuryErythropoietin after a century of research: younger than ever.Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functionsExogenous growth hormone attenuates cognitive deficits induced by intermittent hypoxia in rats.Radix Scrophulariae extracts (harpagoside) suppresses hypoxia-induced microglial activation and neurotoxicity.Advanced targeted nanomedicineNeuroprotection in diet-induced ketotic rat brain after focal ischemia.Growth hormone releasing hormone (GHRH) signaling modulates intermittent hypoxia-induced oxidative stress and cognitive deficits in mouse.Protective effect of 3-(naphthalen-2-yl(propoxy)methyl)azetidine hydrochloride on hypoxia-induced toxicity by suppressing microglial activation in BV-2 cells.Regulation of mRNA following brain ischemia and reperfusion.Regulation of hypoxia-induced inflammatory responses and M1-M2 phenotype switch of primary rat microglia by sex steroids.Modulation of adenosine A1 and A2A receptors in C6 glioma cells during hypoxia: involvement of endogenous adenosine.Prolyl hydroxylase inhibitors depend on extracellular glucose and hypoxia-inducible factor (HIF)-2alpha to inhibit cell death caused by nerve growth factor (NGF) deprivation: evidence that HIF-2alpha has a role in NGF-promoted survival of sympatheti
P2860
Q30429874-D7E2B92C-CAE8-40F8-824B-C61C920F601EQ34066937-40DF1ABC-150B-40C7-B62D-F263468F0E3CQ34606348-4D108E1D-CB31-4A7D-AD20-DF6C13A8043EQ35086167-65E45A3F-5F16-4CFD-A775-F5D3F271A318Q35677223-7FE6FC6A-A5CF-4FEB-98BC-B6B247CF8C33Q35775325-CC0FB4E4-FAD4-4939-958A-384B3881AAC2Q36388931-8B38C162-8253-4AAD-BF82-72317F0CD84BQ36752235-52080864-194E-4EA7-BE7A-650D1C81C994Q37364745-6694AADB-24BC-47A8-9CAD-3FCF1C94678CQ37694131-37362EF2-6A6F-4F12-85F6-5D56C92B2920Q38769167-923F3A20-20DA-4FB3-BC56-FEA9D9AAB3D9Q39069957-5F542243-1C3D-4435-9FC4-091F7F09099AQ40006549-7725C294-C53F-4826-87F3-BD37CAD76F41Q42449110-AB8A78B7-09B4-4BA6-8773-D0FB52365757
P2860
Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders.
@ast
Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders.
@en
type
label
Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders.
@ast
Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders.
@en
prefLabel
Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders.
@ast
Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders.
@en
P356
P1476
Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders.
@en
P2093
Maria Cecilia Barone
Robert S Freeman
P356
10.2174/1568007053005154
P577
2005-02-01T00:00:00Z